MedTrace Logo

Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia

NCT01111981 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2010-04-28

No results posted yet for this study

Summary

The purpose of this study is to ascertain the safety and efficacy of

Clobetasol Propionate 0.05% E Foam in the treatment of Central Centrifugal

Cicatricial Alopecia.

Conditions

Interventions

DRUG

Clobetasol Propionate 0.05% Emollient Foam

Clobetasol Propionate 0.05% E Foam to be applied to affected area once a day for 16 weeks

Sponsors & Collaborators

  • Callender Center for Clinical Research

    lead OTHER

Principal Investigators

  • Valerie Callender, M.D. · Callender Skin for Clinical Research

  • Cherie Young, M.D. · Callender Center for Clinical Research

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-02-28
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01111981 on ClinicalTrials.gov